Impulse Dynamics Announces U.S. FDA Supplemental-PMA Approval of its Next Generation Optimizer® Smart System

by Impulse Dynamics | Oct 30, 2019 | Press Releases

Commercial-Ready Device to Deliver Improved Outcomes to Heart Failure Patients MOUNT LAUREL, N.J. – October 30, 2019 – Impulse Dynamics, developer of the implantable Optimizer Smart System for delivering CCMÔ (Cardiac Contractility Modulation) therapy, announced today...

First Implant in the Kingdom of Saudi Arabia – Continued Global Growth for Impulse Dynamics’ Optimizer IVs Device.

by Impulse Dynamics | Aug 23, 2019 | Press Releases

Stuttgart, Germany – August 23rd, 2015 – Impulse Dynamics announced today (23 August, 2015) the first implantation of its Optimizer IVs device in the Kingdom of Saudi Arabia, at the King Faisal Specialist Hospital & Research Centre (KFSH&RC) in Riyadh. The...

Impulse Dynamics announces appointment of Gerald M. Haines as Executive Vice President and Chief Financial Officer

by Impulse Dynamics | Jul 8, 2019 | News and Events, Press Releases

ORANGEBURG, NY, July 8, 2019 — Impulse Dynamics, developer of the implantable Optimizer® Smart System for delivering CCM™ therapy, announced today the appointment of Gerald M. Haines to the position of Executive Vice President and Chief Financial Officer. Mr....

Impulse Dynamics receives FDA approval for breakthrough Optimizer® Smart System delivering CCM™ therapy for treatment of heart failure

by Impulse Dynamics | Mar 21, 2019 | Press Releases

Orangeburg, New York, March 21, 2019 – Impulse Dynamics, developer of the implantable Optimizer® Smart System for delivering CCM™ therapy, announced today that it has received approval from the United States Food and Drug Administration for its first-in-class...

Clinical Registry Data and recently published FIX-HF-5C were presented at the Late-Breaking Clinical Trial Session at EHF 2018

by Impulse Dynamics | May 28, 2018 | Press Releases

Stuttgart, Germany, May 28th, 2018 – Impulse Dynamics Germany, GmbH announced results on “Real World” experience from its European Clinical Registry. The results were presented today by Prof. Gerd Hasenfuß, MD, Professor of Internal Medicine and Director of the Heart...